TGA urgent product alert for Pfizer BICILLIN L-A benzathine benzylpenicillin tetrahydrate

Queensland Health received the following information on 28 July 2025: 

Bicillin: Pfizer has advised particulates have been identified during visual inspection of certain lots of BICILLIN L-A 1,200,000 Units/ 2.3 mL

The TGA recommend visually inspecting stock before use and if particulates identified syringe should be discarded. Pfizer replacement stock is currently unavailable due to a shortage of the medicine.

Read the TGA product alert

To enquire about alternative stock availability please contact:

• Orspec Pharma can be contacted by telephone on 02 4339 4239 or by email customerservice@orspecpharma.com
• Propharmaceuticals Group can be contacted by telephone on 1300 077 674 or by email customerservice@propg.com.au